2020
DOI: 10.1016/j.jcf.2019.08.006
|View full text |Cite
|
Sign up to set email alerts
|

Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
37
2
2

Year Published

2020
2020
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 66 publications
(43 citation statements)
references
References 39 publications
2
37
2
2
Order By: Relevance
“…Carriage of S. maltophilia is quite common in patients with CF and has been increasing in prevalence since the mid-1990s (9,33). S. maltophilia is widely distributed in a range of environmental sites, including water and soil.…”
Section: Discussionmentioning
confidence: 99%
“…Carriage of S. maltophilia is quite common in patients with CF and has been increasing in prevalence since the mid-1990s (9,33). S. maltophilia is widely distributed in a range of environmental sites, including water and soil.…”
Section: Discussionmentioning
confidence: 99%
“…Our studies found that the most common infectious pathogens in CF patients in China were P. aeruginosa (64.5%), followed by S. aureus (14.0%). Studies have reported the changing prevalence of infections caused by different CF‐associated pathogens according to data from both the North American Cystic Fibrosis Foundation Patient Registry (CFFPR) 60 and the European Registry 61 . The pathogens with the highest prevalence and incidence in 2012 in America were methicillin‐sensitive S. aureus (MSSA) and P. aeruginosa , followed by MRSA, while in 2016 in Europe, the pathogens with the highest prevalence were S. aureus and P. aeruginosa , accounting for 38.3% and 29.8% of cases, respectively.…”
Section: Discussionmentioning
confidence: 99%
“…Although S. maltophilia are thought to be low-grade pathogens and a rather uncommon cause of bacterial disease in humans, they are increasingly recognized as significant opportunistic pathogens in healthcare settings worldwide, being one of the ten most common organisms found in respiratory tissue samples taken from intensive care unit (ICU) patients in Europe (Zuschneid et al, 2007;Gherardi et al, 2015). Several nosocomial outbreaks of S. maltophilia infection and/or colonization have been reported (Denton and Kerr, 1998), and the global prevalence and incidence of these bacteria as human pathogens have increased significantly during the last decade (Chang et al, 2015;Nayyar et al, 2017;Rutter et al, 2017), particularly in cystic fibrosis patients (Hatziagorou et al, 2019). The most common clinical manifestations of S. maltophilia infections include pneumonia, bacteremia, wound or urinary-tract infections (Looney et al, 2009;Gales et al, 2019), with crude mortality rates ranging from 14 to 69% in patients with bacteremia, being highest among patients receiving inappropriate initial antimicrobial therapy (Paez and Costa, 2008;Falagas et al, 2009;Kim et al, 2019).…”
Section: Introductionmentioning
confidence: 99%